Overview
This is an open-label, single-center, non-randomized study to assess the efficacy of Clostridium Butyricum Miyairi on the motor and non-motor symptoms of Parkinson's disease
Description
The physician will explain the trial procedures in the outpatient, and then obtain the written informed consent to start the interview. And randomly divided into experimental and observation groups, and according to the timing of taking Miyarisan, scale evaluation and sample collection.
Eligibility
Inclusion Criteria:
- Male or female over 20 years old, diagnosed with Parkinson's disease.
Exclusion Criteria:
- People with Parkinson's disease Dementia, or Lactose Intolerance